SimianX AI LogoSimianX AI

Asset profile

AXS-05 · Axsome (AXSM)

Indication
agitation associated with dementia due to Alzheimer’s disease
Also known as
dextromethorphan-bupropion, dextromethorphan HBr and bupropion HCl, AUVELITY
CompanyAXSMAxsome

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include …

Start live analysis of AXSMRun 8-agent AI analysis

On the calendar

Timeline

Newest first.

Registered trials

Registry IDPhaseStatusPrimary completionEnrollmentSites
NCT07523048Phase 2RecruitingJul 1, 2026300 of 1 sites in the United States
NCT04947553Phase 3CompletedDec 3, 202445645 of 47 sites in the United States
NCT04019704Phase 3CompletedNov 26, 201932743 of 43 sites in the United States
NCT06736509Phase 3TerminatedFeb 17, 202513921 of 22 sites in the United States
NCT05557409Phase 3CompletedNov 21, 202440853 of 55 sites in the United States
NCT07766655Phase 3RecruitingDec 1, 202770526 of 26 sites in the United States
NCT04797715Phase 3CompletedNov 21, 202217861 of 63 sites in the United States
NCT03471767Phase 2CompletedMar 31, 2019581 of 1 sites in the United States
NCT03226522Phase 2/3CompletedApr 17, 202036677 of 78 sites in the United States
NCT04634669Phase 2TerminatedFeb 18, 202218120 of 20 sites in the United States
NCT04971291Phase 2UnknownJul 1, 20213121 of 1 sites in the United States
NCT04608396Phase 2CompletedJul 30, 20214420 of 20 sites in the United States
NCT05976646Phase 1/2CompletedJul 9, 2025181 of 1 sites in the United States
NCT02741791Phase 3CompletedMar 20, 202031274 of 74 sites in the United States
NCT04039022Phase 3CompletedOct 23, 202087651 of 51 sites in the United States
NCT03595579Phase 2CompletedJan 7, 2019974 of 4 sites in the United States

More from Axsome

Other drugs and candidates from the same company tracked in this sector.

balipodectschizophreniadextromethorphan HBr/bupropion HClagitation associated with dementia due to Alzheimer’s diseasereboxetinecataplexy in narcolepsysolriamfetolADHD in adolescents aged 12 to less than 18 years
AXS-05 · Axsome (AXSM) — FDA Timeline & Readiness Checklist | SimianX AI